$ALGS
Aligos Therapeutics Inc
PRICE
$1.24 ▼-0.8%
Extented Hours
VOLUME
246,074
DAY RANGE
1.11 - 1.27
52 WEEK
1.03 - 34.31
Key Metrics
Market Cap
50.81 M
Beta
1.22
Avg. Volume
453.35 K
Shares Outstanding
42.70 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Website: www.aligos.com
HQ: ,
Related News